Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment. by Oudijk, J, McIlleron, H, Mulenga, V, Chintu, C, Merry, C, Walker, A, Cook, A, Gibb, D, Burger, D

Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. by Soncin, F, Mohamet, L, Eckardt, D, Ritson, S, Eastham, A, Bobola, N, Russell, A, Davies, S, Kemler, R, Merry, C, Ward, C

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications. by Hoglund, R, Byakika-Kibwika, P, Lamorde, M, Merry, C, Ashton, M, Hanpithakpong, W, Day, N, White, N, Abelö, A, Tarning, J

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. by Ryan, M, Griffin, S, Chitah, B, Walker, A, Mulenga, V, Kalolo, D, Hawkins, N, Merry, C, Barry, MG, Chintu, C, Sculpher, M, Gibb, D

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults. by Byakika-Kibwika, P, Lamorde, M, Mayito, J, Nabukeera, L, Mayanja-Kizza, H, Katabira, E, Hanpithakpong, W, Obua, C, Pakker, N, Lindegardh, N, Tarning, J, de Vries, P, Merry, C

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults. by Byakika-Kibwika, P, Lamorde, M, Okaba-Kayom, V, Mayanja-Kizza, H, Katabira, E, Hanpithakpong, W, Pakker, N, Dorlo, T, Tarning, J, Lindegardh, N, de Vries, P, Back, D, Khoo, S, Merry, C

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. by Byakika-Kibwika, P, Lamorde, M, Mayito, J, Nabukeera, L, Namakula, R, Mayanja-Kizza, H, Katabira, E, Ntale, M, Pakker, N, Ryan, M, Hanpithakpong, W, Tarning, J, Lindegardh, N, de Vries, P, Khoo, S, Back, D, Merry, C

Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis. by Banka, S, Cain, SA, Carim, S, Daly, S, Urquhart, J, Erdem, G, Harris, J, Bottomley, M, Donnai, D, Kerr, B, Kingston, H, Superti-Furga, A, Unger, S, Ennis, H, Worthington, J, Herrick, A, Merry, C, Yue, W, Kielty, C, Newman, W

Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break... by Joanne G. Patterson, Tia N. Borger, Jessica L. Burris, Mark Conaway, Robert Klesges, Amie Ashcraft, Lindsay Hauser, Connie Clark, Lauren Wright, Sarah Cooper, Merry C. Smith, Mark Dignan, Stephenie Kennedy-Rea, Electra D. Paskett, Roger Anderson, Amy K. Ferketich

Get full text

An individual participant data population pharmacokinetic meta-analysis of drug-drug interactions between lumefantrine and commonly used antiretroviral treatment by Francis, J, Barnes, KI, Workman, L, Kredo, T, Vestergaard, LS, Hoglund, RM, Byakika-Kibwika, P, Lamorde, M, Walimbwa, SI, Chijioke-Nwauche, I, Sutherland, CJ, Merry, C, Scarsi, KK, Nyagonde, N, Lemnge, MM, Khoo, SH, Bygbjerg, IC, Parikh, S, Aweeka, FT, Tarning, J, Denti, P

Second assessment of NeuroAIDS in Africa. by Robertson, K, Kopnisky, K, Hakim, J, Merry, C, Nakasujja, N, Hall, C, Traore, M, Sacktor, N, Clifford, D, Newton, C, Van Rie, A, Holding, P, Clements, J, Zink, C, Mielk, J, Hosseinipour, M, Lalloo, U, AMod, F, Marra, C, Evans, S, Liner, J